Correlation Between Anebulo Pharmaceuticals and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Lyra Therapeutics, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Lyra Therapeutics.
Diversification Opportunities for Anebulo Pharmaceuticals and Lyra Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Anebulo and Lyra is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Lyra Therapeutics
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Lyra Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.52 times less risky than Lyra Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Lyra Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 27.00 in Lyra Therapeutics on September 1, 2024 and sell it today you would lose (6.00) from holding Lyra Therapeutics or give up 22.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Lyra Therapeutics
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Lyra Therapeutics |
Anebulo Pharmaceuticals and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Lyra Therapeutics
The main advantage of trading using opposite Anebulo Pharmaceuticals and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Anebulo Pharmaceuticals vs. Tff Pharmaceuticals | Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. Inhibrx | Anebulo Pharmaceuticals vs. Enliven Therapeutics |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |